Mga Industriya

• Reset all ×
• Pangangalaga sa Kalusugan & Mga Agham sa Buhay ×

Showing 41–50 ng mga 134 results

Sort by popularity Sort by average rating Sort by latest Sort by price: low to high Sort by price: high to low

• 

  Melanoma Market in China

  According to a statistic by StrategyHelix, the melanoma market in China, sa dami ng mga tuntunin, is expected to expand at a CAGR of 2.2% sa susunod na limang taon.

  USD 10
• 

  Oncolytic Virus Therapy Market in China

  The oncolytic virus therapy market in China is poised to grow by US$ 1,913 milyon sa panahon ng 2021-2027, umuusad sa isang CAGR ng 41.8% sa panahon ng pagtataya, ayon sa data at analytics company na StrategyHelix.

  USD 5
• 

  Bladder Cancer Market in China

  Ayon sa StrategyHelix, the bladder cancer market in China, sa dami ng mga tuntunin, is expected to expand at a CAGR of 3.1% sa panahon ng pagsusuri ng 2021 sa 2027.

  USD 5
• 

  Pancreatic Cancer Market in China

  According to a statistic by StrategyHelix, the pancreatic cancer market in China, sa dami ng mga tuntunin, is expected to expand at a CAGR of 3.3% sa panahon ng pagtataya (2021-2027).

  USD 5
• 

  Lymphoma Market in China

  Ayon sa StrategyHelix, the lymphoma market in China, sa dami ng mga tuntunin, is expected to expand at a CAGR of 2.3% sa susunod na limang taon.

  USD 10
• 

  Urothelial Cancer Market in China

  According to a statistic by StrategyHelix, the urothelial cancer market in China, sa dami ng mga tuntunin, is expected to expand at a CAGR of 3.2% mula sa 2021 sa pamamagitan ng 2027.

  USD 5
• 

  Global Gastric Cancer Market

  At 3% CAGR, the global gastric cancer market, sa dami ng mga tuntunin, is projected to reach 1,333 thousand units by 2027, ayon sa data at analytics company na StrategyHelix.

  USD 10
• 

  Gastric Cancer Market in China

  The gastric cancer market in China was estimated at 470 libong units sa 2020 and is anticipated to reach 579 thousand units by 2027, umuusad sa isang CAGR ng 3% throughout the forecast period, ayon sa StrategyHelix.

  USD 10
• 

  Breast Cancer Market in China

  Ayon sa StrategyHelix, the breast cancer market in China, sa dami ng mga tuntunin, is expected to expand at a CAGR of 1.2% mula sa 2021 sa pamamagitan ng 2027.

  USD 5
• 

  Global Non-small-cell Lung Carcinoma (NSCLC) Market

  According to a statistic by StrategyHelix, the global non-small-cell lung carcinoma (NSCLC) market is poised to grow at a CAGR of around 15.4% sa panahon ng pagsusuri ng 2021 sa 2027.

  USD 5